The global Primaquine Phosphate API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Primaquine Phosphate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Primaquine Phosphate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Primaquine Phosphate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Primaquine Phosphate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Primaquine Phosphate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Primaquine Phosphate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Primaquine Phosphate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan Laboratorie, Ipca Laboratories, Mangalam Drugs & Organics, Ralington Pharma, Chongqing Southwest No.2 Pharmaceutical Factory, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Primaquine Phosphate API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity Above 98%
Purity Below 98%
Market segment by Application
Tablet
Others
Major players covered
Mylan Laboratorie
Ipca Laboratories
Mangalam Drugs & Organics
Ralington Pharma
Chongqing Southwest No.2 Pharmaceutical Factory
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Primaquine Phosphate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Primaquine Phosphate API, with price, sales quantity, revenue, and global market share of Primaquine Phosphate API from 2020 to 2025.
Chapter 3, the Primaquine Phosphate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primaquine Phosphate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Primaquine Phosphate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Primaquine Phosphate API.
Chapter 14 and 15, to describe Primaquine Phosphate API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Primaquine Phosphate API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Purity Above 98%
1.3.3 Purity Below 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Primaquine Phosphate API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Tablet
1.4.3 Others
1.5 Global Primaquine Phosphate API Market Size & Forecast
1.5.1 Global Primaquine Phosphate API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Primaquine Phosphate API Sales Quantity (2020-2031)
1.5.3 Global Primaquine Phosphate API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Mylan Laboratorie
2.1.1 Mylan Laboratorie Details
2.1.2 Mylan Laboratorie Major Business
2.1.3 Mylan Laboratorie Primaquine Phosphate API Product and Services
2.1.4 Mylan Laboratorie Primaquine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Mylan Laboratorie Recent Developments/Updates
2.2 Ipca Laboratories
2.2.1 Ipca Laboratories Details
2.2.2 Ipca Laboratories Major Business
2.2.3 Ipca Laboratories Primaquine Phosphate API Product and Services
2.2.4 Ipca Laboratories Primaquine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Ipca Laboratories Recent Developments/Updates
2.3 Mangalam Drugs & Organics
2.3.1 Mangalam Drugs & Organics Details
2.3.2 Mangalam Drugs & Organics Major Business
2.3.3 Mangalam Drugs & Organics Primaquine Phosphate API Product and Services
2.3.4 Mangalam Drugs & Organics Primaquine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Mangalam Drugs & Organics Recent Developments/Updates
2.4 Ralington Pharma
2.4.1 Ralington Pharma Details
2.4.2 Ralington Pharma Major Business
2.4.3 Ralington Pharma Primaquine Phosphate API Product and Services
2.4.4 Ralington Pharma Primaquine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Ralington Pharma Recent Developments/Updates
2.5 Chongqing Southwest No.2 Pharmaceutical Factory
2.5.1 Chongqing Southwest No.2 Pharmaceutical Factory Details
2.5.2 Chongqing Southwest No.2 Pharmaceutical Factory Major Business
2.5.3 Chongqing Southwest No.2 Pharmaceutical Factory Primaquine Phosphate API Product and Services
2.5.4 Chongqing Southwest No.2 Pharmaceutical Factory Primaquine Phosphate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Chongqing Southwest No.2 Pharmaceutical Factory Recent Developments/Updates
3 Competitive Environment: Primaquine Phosphate API by Manufacturer
3.1 Global Primaquine Phosphate API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Primaquine Phosphate API Revenue by Manufacturer (2020-2025)
3.3 Global Primaquine Phosphate API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Primaquine Phosphate API by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Primaquine Phosphate API Manufacturer Market Share in 2024
3.4.3 Top 6 Primaquine Phosphate API Manufacturer Market Share in 2024
3.5 Primaquine Phosphate API Market: Overall Company Footprint Analysis
3.5.1 Primaquine Phosphate API Market: Region Footprint
3.5.2 Primaquine Phosphate API Market: Company Product Type Footprint
3.5.3 Primaquine Phosphate API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Primaquine Phosphate API Market Size by Region
4.1.1 Global Primaquine Phosphate API Sales Quantity by Region (2020-2031)
4.1.2 Global Primaquine Phosphate API Consumption Value by Region (2020-2031)
4.1.3 Global Primaquine Phosphate API Average Price by Region (2020-2031)
4.2 North America Primaquine Phosphate API Consumption Value (2020-2031)
4.3 Europe Primaquine Phosphate API Consumption Value (2020-2031)
4.4 Asia-Pacific Primaquine Phosphate API Consumption Value (2020-2031)
4.5 South America Primaquine Phosphate API Consumption Value (2020-2031)
4.6 Middle East & Africa Primaquine Phosphate API Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Primaquine Phosphate API Sales Quantity by Type (2020-2031)
5.2 Global Primaquine Phosphate API Consumption Value by Type (2020-2031)
5.3 Global Primaquine Phosphate API Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Primaquine Phosphate API Sales Quantity by Application (2020-2031)
6.2 Global Primaquine Phosphate API Consumption Value by Application (2020-2031)
6.3 Global Primaquine Phosphate API Average Price by Application (2020-2031)
7 North America
7.1 North America Primaquine Phosphate API Sales Quantity by Type (2020-2031)
7.2 North America Primaquine Phosphate API Sales Quantity by Application (2020-2031)
7.3 North America Primaquine Phosphate API Market Size by Country
7.3.1 North America Primaquine Phosphate API Sales Quantity by Country (2020-2031)
7.3.2 North America Primaquine Phosphate API Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Primaquine Phosphate API Sales Quantity by Type (2020-2031)
8.2 Europe Primaquine Phosphate API Sales Quantity by Application (2020-2031)
8.3 Europe Primaquine Phosphate API Market Size by Country
8.3.1 Europe Primaquine Phosphate API Sales Quantity by Country (2020-2031)
8.3.2 Europe Primaquine Phosphate API Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Primaquine Phosphate API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Primaquine Phosphate API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Primaquine Phosphate API Market Size by Region
9.3.1 Asia-Pacific Primaquine Phosphate API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Primaquine Phosphate API Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Primaquine Phosphate API Sales Quantity by Type (2020-2031)
10.2 South America Primaquine Phosphate API Sales Quantity by Application (2020-2031)
10.3 South America Primaquine Phosphate API Market Size by Country
10.3.1 South America Primaquine Phosphate API Sales Quantity by Country (2020-2031)
10.3.2 South America Primaquine Phosphate API Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Primaquine Phosphate API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Primaquine Phosphate API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Primaquine Phosphate API Market Size by Country
11.3.1 Middle East & Africa Primaquine Phosphate API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Primaquine Phosphate API Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Primaquine Phosphate API Market Drivers
12.2 Primaquine Phosphate API Market Restraints
12.3 Primaquine Phosphate API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Primaquine Phosphate API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Primaquine Phosphate API
13.3 Primaquine Phosphate API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Primaquine Phosphate API Typical Distributors
14.3 Primaquine Phosphate API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Mylan Laboratorie
Ipca Laboratories
Mangalam Drugs & Organics
Ralington Pharma
Chongqing Southwest No.2 Pharmaceutical Factory
听
听
*If Applicable.
